Comment · Mon, February 15, 2021 · ND Owner
GHK, Beta Lapachone, and Tetramethylpyrazine
Original post in this thread
Darkhorseman81 · 7 points
There are some studies seeming to show that GHK and GHK-Cu could be interesting substances, though I am not sure its just the guy working on them trying to market a product.
I am also interested in Beta Lapachone, and Tetramethylpyrazine if it can be made more bioavailable.
Don't suppose you are at all interested in marketing any of these products? Some seem bordering on pharmaceutical. I've already combined some into a protein powder.
* https://www.hindawi.com/journals/bmri/2014/151479/
* https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332963/
* https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0047122
* https://www.hindawi.com/journals/omcl/2020/8820651/
* https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421748/
* [https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0355-z](https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-015-0355…
What they were answering
Direct reply to the original post — see the thread post above.
u/MisterYouAreSoDumb · ND Owner
We were one of the first to bring out GHK-Cu back on Ceretropic. We did a lot of novel peptides back then. However, the legal and regulatory risk of peptides in the US is insanely higher than other compounds. We still make GHK and GHK-Cu. We never stopped. We just don't sell peptides in the US anymore. There was sort of a minor lull in the enforcement during Trump, since he gutted the FDA budget. However, the legal framework has not changed, and the FDA has made it clear they are tracking everyone and just waiting for their budget to be restored to start going after everyone again. I don't think anyone is thinking the Biden administration is going to do anything but try to restore the FDA budget, or even increase it. This means FDA enforcement on peptides is only going to increase in the next couple years. Multiple vendors went to prison for them, which is no bueno. Anyone selling peptides in the US right now is playing musical chairs, and the music will stop soon.